I agree that this site is using cookies. You can find further informations here.
X
Kontkanen, Aleksi
9  results:
Search for persons X
?
1

Serum GFAP and NfL levels in benign relapsing-remitting mul..:

Niiranen, Marja ; Kontkanen, Aleksi ; Jääskeläinen, Olli...
Multiple Sclerosis and Related Disorders.  56 (2021)  - p. 103280 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Serum neurofilament light chain in FTLD: association with C..:

Cajanus, Antti ; Katisko, Kasper ; Kontkanen, Aleksi...
Annals of Clinical and Translational Neurology.  7 (2020)  6 - p. 903-910 , 2020
Link: https://doi.org/10.1002/..
 
?
3

Serum neurofilament light chain is a discriminative biomark..:

Katisko, Kasper ; Cajanus, Antti ; Jääskeläinen, Olli...
Journal of Neurology.  267 (2019)  1 - p. 162-167 , 2019
Link: https://doi.org/10.1007/..
 
?
4

Peripheral inflammatory markers and clinical correlations i..:

Katisko, Kasper ; Solje, Eino ; Korhonen, Paula...
Journal of Neurology.  267 (2019)  1 - p. 76-86 , 2019
Link: https://doi.org/10.1007/..
 
?
5

Serum GFAP and NfL levels in benign relapsing-remitting mul..:

Niiranen, Marja ; Kontkanen, Aleksi ; Jääskeläinen, Olli...
Multiple sclerosis and related disorders.  , 2022
Link: https://erepo.uef.fi/han..
 
?
6

Serum neurofilament light chain in FTLD:association with C9..:

Cajanus, A. (Antti) ; Katisko, K. (Kasper) ; Kontkanen, A. (Aleksi)... , 2020
Link: http://urn.fi/urn:nbn:fi..
 
?
7

Serum neurofilament light chain in FTLD: association with C..:

Cajanus, Antti ; Katisko, Kasper ; Kontkanen, Aleksi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318100/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
8

Rinnakkaisohjelmointi .NET-ympäristössä:

Kontkanen, Aleksi ; Lappalainen, Juho
URN:NBN:fi:amk-2014110315170.  , 2014
Link: http://www.theseus.fi/ha..
 
?
9

Serum neurofilament light chain in FTLD: association with C..:

Antti Cajanus ; Kasper Katisko ; Aleksi Kontkanen...
https://doi.org/10.1002/acn3.51041.  , 2020
Link: https://doi.org/10.1002/..
 
1-9